Alessandro Casini1, Hanny Al-Samkari2, Catherine Hayward3
1Division of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland.
Rare bleeding disorders (RBDs) management remains challenging, with limited treatment options beyond factor replacement. Further research is needed to optimize therapies for inherited fibrinogen disorders, platelet function disorders, and hereditary hemorrhagic telangiectasia.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: